Abdominal aortic aneurysm (AAA) causes∼ 170 000 deaths annually worldwide. Most
guidelines recommend asymptomatic small AAAs (30 to< 50 mm in women; 30 to< 55 mm in …

Abdominal aortic aneurysm: novel mechanisms and therapies : Current Opinion in
Cardiology Abdominal aortic aneurysm: novel mechanisms and therapies : Current Opinion …

Background Decision-making related to the care of patients with an abdominal aortic
aneurysm (AAA) is complex. Aneurysms present with varying risks of rupture, and patient …

Background: Large-scale human and mechanistic mouse studies indicate a strong
relationship between the microbiome-dependent metabolite trimethylamine N-oxide (TMAO) …

Abdominal aortic aneurysm (AAA) is a lethal cardiovascular disease, and there is no proven
drug treatment for this condition. In this study, by using the Connectivity Map (CMap) …

Rationale Aortic aneurysm (AA) is a serious condition that largely increases the risk of aortic
dissection and sudden death. Exploring the global burden of disease and changes in risk …

Background: Abdominal aortic aneurysm (AAA), a progressive segmental abdominal aortic
dilation, is associated with high mortality. AAA is characterized by inflammation, smooth …

Importance The associations between long-term treatment of aortic dissection with various
medications and late patient outcomes are poorly understood. Objective To compare late …

Aims Little is known about the prevalence of aortic aneurysms among people living with HIV
(PLWH). We investigated whether HIV status is independently associated with having aortic …

Abdominal aortic aneurysm (AAA) was previously ascribed to weaken defective medial
arterial/adventitial layers, for example, smooth muscle/fibroblast cells. Therefore, besides …